scholarly article | Q13442814 |
P50 | author | John T Belisle | Q38548374 |
Gary P Wormser | Q105913150 | ||
P2093 | author name string | Ann M Hess | |
Mark J Delorey | |||
Martin E Schriefer | |||
Sebabrata Mahapatra | |||
Laura V Ashton | |||
Claudia R Molins | |||
P2860 | cites work | Diagnosis of lyme borreliosis | Q22242237 |
Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme Immunoassay | Q22242917 | ||
Early Lyme Disease | Q22250897 | ||
Erythema Migrans | Q22252199 | ||
HMDB: a knowledgebase for the human metabolome | Q24655295 | ||
Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases: The Short-Term and Long-Term Outcomes: Workshop Report | Q26827556 | ||
Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS) | Q28681060 | ||
Lyme borreliosis | Q29013670 | ||
Regularization Paths for Generalized Linear Models via Coordinate Descent | Q29614491 | ||
METLIN: a metabolite mass spectral database | Q29614808 | ||
ROCR: visualizing classifier performance in R | Q29615821 | ||
Application of machine learning to proteomics data: classification and biomarker identification in postgenomics biology | Q30676067 | ||
Robust classification modeling on microarray data using misclassification penalized posterior | Q30992256 | ||
Normalization method for metabolomics data using optimal selection of multiple internal standards | Q31105641 | ||
Serum inflammatory mediators as markers of human Lyme disease activity | Q31158874 | ||
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease | Q33738269 | ||
Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation | Q34298182 | ||
Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease | Q34301091 | ||
Western blotting in the serodiagnosis of Lyme disease | Q34355106 | ||
Innate immunity networks during infection with Borrelia burgdorferi | Q34426426 | ||
Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness | Q34541505 | ||
Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins | Q34721407 | ||
The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism | Q34762629 | ||
Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease. | Q36040985 | ||
Lyme disease testing by large commercial laboratories in the United States. | Q36283952 | ||
Immune responses induced by spirochetal outer membrane lipoproteins and glycolipids | Q37136167 | ||
A metabolic biosignature of early response to anti-tuberculosis treatment | Q37569320 | ||
Exploring disease through metabolomics | Q37658632 | ||
Integrative system biology strategies for disease biomarker discovery | Q37973426 | ||
Implementation of liquid chromatography/mass spectrometry into the clinical laboratory | Q38053816 | ||
The role of eicosanoids in experimental Lyme arthritis. | Q38218131 | ||
Metabonomic investigation of human Schistosoma mansoni infection | Q38870788 | ||
Metabolic profiling framework for discovery of candidate diagnostic markers of malaria. | Q39534292 | ||
Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease | Q40201592 | ||
Serum levels of interleukin-18 (IL-18), interleukin-1beta (IL-1beta), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritis | Q44645047 | ||
Prevalence of Borrelia burgdorferi (Spirochaetales: Spirochaetaceae), Anaplasma phagocytophilum (Rickettsiales: Anaplasmataceae), and Babesia microti (Piroplasmida: Babesiidae) in Ixodes scapularis (Acari: Ixodidae) collected from recreational lands | Q51463029 | ||
New Tables for Multiple Comparisons with a Control | Q56913601 | ||
Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry | Q56974325 | ||
A preliminary study of C-reactive protein in the diagnosis and monitoring of Lyme disease | Q71957451 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Lyme disease | Q201989 |
P304 | page(s) | 1767-1775 | |
P577 | publication date | 2015-03-11 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Development of a metabolic biosignature for detection of early Lyme disease | |
P478 | volume | 60 |
Q98466652 | A Practical Approach to the Diagnosis of Lyme Borreliosis: From Clinical Heterogeneity to Laboratory Methods |
Q55133030 | A multi-omic analysis reveals the regulatory role of CD180 during the response of macrophages to Borrelia burgdorferi. |
Q49628856 | Accuracy of Clinician Suspicion of Lyme Disease in the Emergency Department. |
Q36275562 | Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada |
Q89610372 | Borrelia burgdorferi hijacks cellular metabolism of immune cells: Consequences for host defense |
Q30357899 | Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States. |
Q36764399 | Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease |
Q58778284 | Identification of Urine Metabolites as Biomarkers of Early Lyme Disease |
Q36687055 | Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease |
Q36112203 | Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples |
Q56764150 | Lyme borreliosis |
Q40091071 | Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI). |
Q42696026 | Metabolic phenotyping in the mouse model of urinary tract infection shows that 3-hydroxybutyrate in plasma is associated with infection |
Q64947879 | Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution. |
Q37695689 | Metabolomics of the tick-Borrelia interaction during the nymphal tick blood meal |
Q35935426 | Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes |
Q64926379 | NMR metabolome of Borrelia burgdorferi in vitro and in vivo in mice. |
Q60952351 | NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system |
Q100737071 | Predicting human health from biofluid-based metabolomics using machine learning |
Q52589111 | Proteomic analysis at the sites of clinical infection with invasive Streptococcus pyogenes. |
Q28075680 | The Past, Present, and (Possible) Future of Serologic Testing for Lyme Disease |
Q37679914 | The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection |
Q55496706 | Variable selection in omics data: A practical evaluation of small sample sizes. |
Q30376327 | What was old is new again: using the host response to diagnose infectious disease. |
Search more.